Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Number of shares outstanding for Celltrion
(068270.KS)
Number of shares outstanding as of January 2025 : 206,380,222
According to Celltrion
's latest financial reports and stock price the company's current number of shares outstanding is 206,380,222. At the end of 2024 the company had 206,380,222 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Celltrion
from 2023 to 2024
Shares Outstanding at the end of each year
Year
Shares Outstanding
Change
2024
0.20 B
45.38%
2023
0.14 B
-4.85%
2022
0.14 B
Propose a change
Your message has been sent!
An error has occured, please write us an E-Mail
Edit suggestions are usually processed within 48hours.